Targeting the PDGF/PDGFR signaling pathway for cancer therapy: A review

X Zou, XY Tang, ZY Qu, ZW Sun, CF Ji, YJ Li… - International Journal of …, 2022 - Elsevier
Platelet-derived growth factors (PDGFs) and PDGF receptors (PDGFRs) are expressed in a
variety of tumors. Activation of the PDGF/PDGFR signaling pathway is associated with …

Dissecting metastasis using preclinical models and methods

JD Hebert, JW Neal, MM Winslow - Nature Reviews Cancer, 2023 - nature.com
Metastasis has long been understood to lead to the overwhelming majority of cancer-related
deaths. However, our understanding of the metastatic process, and thus our ability to …

[HTML][HTML] Pericytes in the tumor microenvironment

Z Jiang, J Zhou, L Li, S Liao, J He, S Zhou, Y Zhou - Cancer letters, 2023 - Elsevier
Pericytes are a type of mural cell located between the endothelial cells of capillaries and the
basement membrane, which function to regulate the capillary vasomotor and maintain …

Glial and myeloid heterogeneity in the brain tumour microenvironment

BM Andersen, C Faust Akl, MA Wheeler… - Nature Reviews …, 2021 - nature.com
Brain cancers carry bleak prognoses, with therapeutic advances helping only a minority of
patients over the past decade. The brain tumour microenvironment (TME) is highly …

Breast cancer dormancy: need for clinically relevant models to address current gaps in knowledge

GG Bushnell, AP Deshmukh, P den Hollander… - NPJ breast …, 2021 - nature.com
Breast cancer is the most commonly diagnosed cancer in the USA. Although advances in
treatment over the past several decades have significantly improved the outlook for this …

PDGFB-targeted functional MRI nanoswitch for activatable T1–T2 dual-modal ultra-sensitive diagnosis of cancer

Y Zhang, L Liu, W Li, C Zhang, T Song, P Wang… - Journal of …, 2023 - Springer
As one of the most significant imaging modalities currently available, magnetic resonance
imaging (MRI) has been extensively utilized for clinically accurate cancer diagnosis …

An overview of agents and treatments for PDGFRA-mutated gastrointestinal stromal tumors

Y Sun, L Yue, P Xu, W Hu - Frontiers in Oncology, 2022 - frontiersin.org
Platelet-derived growth factor receptor A (PDGFRA) mutations occur in approximately 10–
15% of gastrointestinal stromal tumors (GISTs). These tumors with PDGFRA mutations have …

PDGFB targeting biodegradable FePt alloy assembly for MRI guided starvation-enhancing chemodynamic therapy of cancer

C Zhang, Z Leng, Y Wang, L Ran, X Qin, H Xin… - Journal of …, 2022 - Springer
The application of chemodynamic therapy (CDT) for cancer is a serious challenge owing to
the low efficiency of the Fenton catalyst and insufficient H2O2 expression in cells. Herein, we …

Tumor biomarkers for diagnosis, prognosis and targeted therapy

Y Zhou, L Tao, J Qiu, J Xu, X Yang, Y Zhang… - … and Targeted Therapy, 2024 - nature.com
Tumor biomarkers, the substances which are produced by tumors or the body's responses to
tumors during tumorigenesis and progression, have been demonstrated to possess critical …

Blood vessel resident human stem cells in health and disease

DJ Craig, AW James, Y Wang, M Tavian… - Stem Cells …, 2022 - academic.oup.com
The vascular wall is comprised of distinct layers controlling angiogenesis, blood flow, vessel
anchorage within organs, and cell and molecule transit between blood and tissues …